These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7817339)

  • 1. [Hemoptysis under acenocoumarol: role of the arrest of enzymatic inductor (carbamazepine)].
    Rivière I; Barjhoux C; Mallaret M
    Therapie; 1994; 49(2):142-3. PubMed ID: 7817339
    [No Abstract]   [Full Text] [Related]  

  • 2. [Patient with haemoptysis, dyspnoea, fever and lung infiltration].
    Zielińska-Leś I; Kozielski J; Kamiński J
    Wiad Lek; 2006; 59(3-4):289-91. PubMed ID: 16813283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 2C9 polymorphism and acenocoumarol therapy.
    Mark L; Marki-Zay J; Fodor L; Hajdara I; Paragh G; Katona A
    Kardiol Pol; 2006 Apr; 64(4):397-402; discussion 403-4. PubMed ID: 16699986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of cytochrome P450 2C9 genotype for the bleeding complications in patients treated with acenocoumarol].
    Márk L; Márki-Zay J; Fodor L; Kondacs A; Paragh G; Katona A
    Orv Hetil; 2005 Apr; 146(16):739-43. PubMed ID: 15889670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ileus with the use of acenocoumarol].
    Logman WG
    Ned Tijdschr Geneeskd; 1967 Jun; 111(23):1056. PubMed ID: 6044083
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ileus caused by the use of acenocoumarol].
    de Boer HH
    Ned Tijdschr Geneeskd; 1967 Apr; 111(15):675-8. PubMed ID: 6047044
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adverse effects of combined use of acenocoumarol and acetylsalicylic acid after myocardial infarct and unstable angina].
    Sámóczi M; Farkas A; Sipos E; Tarján J
    Orv Hetil; 1995 Jan; 136(4):177-9. PubMed ID: 7870411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Potentiation of acenocoumarol after application of an semi-synthetic heparinoid].
    Potel G; Maulaz B; Pabceuf C; Toyze MD; Baron D
    Therapie; 1989; 44(1):67-8. PubMed ID: 2472016
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacogenetics of acenocoumarol: cytochrome P450 CYP2C9 polymorphisms influence dose requirements and stability of anticoagulation.
    Tàssies D; Freire C; Pijoan J; Maragall S; Monteagudo J; Ordinas A; Reverter JC
    Haematologica; 2002 Nov; 87(11):1185-91. PubMed ID: 12414349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypocoagulation caused by thiabendazole-acenocoumarol interaction].
    Henri P; Mosquet B; Hurault de Ligny B; Lacotte J; Cardinau E; Moulin M; Ryckelinck JP
    Therapie; 1993; 48(5):500-1. PubMed ID: 8146845
    [No Abstract]   [Full Text] [Related]  

  • 11. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.
    Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A
    Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The possibility of intestinal hemorrhage in long-term use of acenocoumarol; a cohort study].
    van der Meer FJ; Rosendaal FR
    Ned Tijdschr Geneeskd; 1993 Jun; 137(25):1267-8. PubMed ID: 8327015
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acenocoumarol as the trigger of disseminated intravascular coagulation in a patient with cancer].
    Rodríguez JA; Aguilera MC; Galende del Canto J; García MA
    Sangre (Barc); 1999 Dec; 44(6):490-1. PubMed ID: 10822766
    [No Abstract]   [Full Text] [Related]  

  • 14. Acenocoumarol and vasculitis: a case report.
    Aouam K; Gassab A; Khorchani H; Bel Hadj Ali H; Amri M; Boughattas NA; Zili JE
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):113-4. PubMed ID: 16981216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acenocoumarol-induced leukocytoclastic vasculitis.
    Jiménez-Gonzalo FJ; Medina-Pérez M; Marín-Martín J
    Haematologica; 1999 May; 84(5):462-3. PubMed ID: 10329927
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemoptysis developing soon after use of sildenafil: an observation on two cases.
    Yuncu G; Ozkurt S; Sinik Z; Kiter G
    Asian J Androl; 2006 Nov; 8(6):757-8. PubMed ID: 16752000
    [No Abstract]   [Full Text] [Related]  

  • 17. Potentiation of acenocoumarol action by L-carnitine.
    Martinez E; Domingo P; Roca-Cusachs A
    J Intern Med; 1993 Jan; 233(1):94. PubMed ID: 8429297
    [No Abstract]   [Full Text] [Related]  

  • 18. [Upper airway obstruction as a complication of acenocoumarol treatment].
    García Callejo FJ; Velert Villa MM
    Sangre (Barc); 1998 Jun; 43(3):223-6. PubMed ID: 9741230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acenocoumarol-induced Henoch-Schönlein purpura.
    Borrás-Blasco J; Girona E; Navarro-Ruiz A; Matarredona J; Giménez ME; Gutiérrez A; Enriquez R; Martinez A
    Ann Pharmacother; 2004 Feb; 38(2):261-4. PubMed ID: 14742763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute dyspnea and maculo-papular eruption after taking acenocoumarol (Sintrom].
    Kamm W; Berger JP
    Rev Med Suisse Romande; 1998 Jun; 118(6):565-8. PubMed ID: 9689868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.